Drugs by condition
Drugs approved for asthma
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
51
Still marketed, NDA or BLA
Drug classes
9
Novel drugs
17
New molecular entities and new biologics
In development
40+
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for asthma.
- Exdensur (Depemokimab-Ulaa) · Glaxosmithkline LLC NovelDec 16, 2025
- Omlyclo (Omalizumab-Igec) · Celltrion INC Mar 7, 2025
- Airsupra (Albuterol Sulfate, Budesonide) · Astrazeneca Jan 10, 2023
- Tezspire (Tezepelumab-Ekko) · Astrazeneca Ab NovelPriority reviewDec 17, 2021
- Nucala (Mepolizumab) · Glaxosmithkline OrphanJun 6, 2019
All approved drugs for asthma, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 235 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Corticosteroid (7)
- Medrol Methylprednisolone · Pfizer · 1957
- Airsupra Albuterol Sulfate, Budesonide · Astrazeneca · 2023
- Symbicort Budesonide, Formoterol Fumarate Dihydrate · Astrazeneca · 2006
- Pulmicort Flexhaler Budesonide · Cheplapharm · 2006
- Pulmicort Respules Budesonide · Astrazeneca · 2000
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Interleukin-5 Antagonist (3)
Anti-IgE (2)
Thymic Stromal Lymphopoietin Blocker (1)
- Tezspire Tezepelumab-Ekko · Astrazeneca Ab · 2021
Interleukin-5 Receptor alpha-directed Cytolytic Antibody (1)
- Fasenra Benralizumab · Astrazeneca Ab · 2017
Interleukin-4 Receptor alpha Antagonist (1)
- Dupixent Dupilumab · Regeneron Pharmaceuticals · 2017
Neuraminidase Inhibitor (1)
- Relenza Zanamivir · Glaxosmithkline · 1999
Leukotriene Receptor Antagonist (1)
- Accolate Zafirlukast · Strides Pharma Intl · 1996
Class not listed in FDA's data (34)
- Exdensur Depemokimab-Ulaa · Glaxosmithkline LLC · 2025
- Striverdi Respimat Olodaterol Hydrochloride · Boehringer Ingelheim · 2014
- Anoro Ellipta Umeclidinium Bromide, Vilanterol Trifenatate · Glaxosmithkline · 2013
- Breo Ellipta Fluticasone Furoate, Vilanterol Trifenatate · Glaxo Grp LTD · 2013
- Singulair Montelukast Sodium · Organon · 1998
- Provocholine Methacholine Chloride · Methapharm · 1986
- Betoptic Betaxolol Hydrochloride · Sandoz · 1985
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Trelegy Ellipta Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate · Glaxosmithkline · 2017
- Qvar Redihaler Beclomethasone Dipropionate · Norton Waterford · 2017
- Airduo Digihaler Fluticasone Propionate, Salmeterol Xinafoate · Teva Pharm · 2017
- Bevespi Aerosphere Formoterol Fumarate, Glycopyrrolate · Astrazeneca · 2016
- Spiriva Respimat Tiotropium Bromide · Boehringer Ingelheim · 2015
- Stiolto Respimat Olodaterol Hydrochloride, Tiotropium Bromide · Boehringer Ingelheim · 2015
- Spiriva Respimat Tiotropium Bromide · Boehringer Ingelheim · 2014
- Arnuity Ellipta Fluticasone Furoate · Glaxosmithkline · 2014
- Asmanex Hfa Mometasone Furoate · Organon LLC · 2014
- Aridol Kit Mannitol · Pharmaxis Europe · 2010
- Dulera Formoterol Fumarate, Mometasone Furoate · Organon LLC · 2010
- Alvesco Ciclesonide · Azurity · 2008
- Perforomist Formoterol Fumarate · Viatris Specialty · 2007
- Advair Hfa Fluticasone Propionate, Salmeterol Xinafoate · Glaxo Grp LTD · 2006
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Asmanex Twisthaler Mometasone Furoate · Organon LLC · 2005
- Flovent Hfa Fluticasone Propionate · Glaxo Grp LTD · 2004
- Flovent Diskus 250 Fluticasone Propionate · Glaxo Grp LTD · 2000
- Advair Diskus 500/50 Fluticasone Propionate, Salmeterol Xinafoate · Glaxo Grp LTD · 2000
- Singulair Montelukast Sodium · Organon · 1998
- Serevent Salmeterol Xinafoate · Glaxosmithkline · 1997
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Brethine Terbutaline Sulfate · Ani Pharms · 1976
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for asthma
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- PovorcitinibINCB054707, INCB54707Phase 312 trials
Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis
- CM512Phase 39 trials
Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma
- LP-003SinglePhase 39 trials
Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies
- LunsekimigSAR443765Phase 39 trials
Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps
- GSK5784283Phase 38 trials
GSK · Pulmonary Disease, Chronic Obstructive, Asthma, Nasal Polyps
- PF-07275315tilrekimigPhase 38 trials
Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease
- MG-K10Humanized Monoclonal AntibodyPhase 36 trials
Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis
- SHR-1905Phase 36 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis
- TozorakimabMEDI3506Phase 36 trials
AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD), Asthma, Viral Lung Infection and Acute Respiratory Failure
- CM310Phase 35 trials
Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease
- JYB1904RPT904, ozureprubartPhase 35 trials
Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases
- TQC2731Phase 35 trials
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- BFFBFF MDI 320, BFF MDI 160Phase 34 trials
AstraZeneca · Asthma
- BGF MDI 320BGFPhase 33 trials
AstraZeneca · Asthma, COPD (Chronic Obstructive Pulmonary Disease)
- CM326Phase 33 trials
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Moderate to Severe Asthma
- HSK31858Phase 33 trials
Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis
- 000 MG01Phase 32 trials
Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
- 000 MM09Phase 32 trials
Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
- BD MDIPhase 32 trials
AstraZeneca · Asthma
- Dexpramipexole DihydrochloridePhase 32 trials
Areteia Therapeutics · Chronic Obstructive Pulmonary Disease, Eosinophilic Asthma, Asthma; Eosinophilic
3 discontinued brand-name drugs whose label still names it
- Zyflo Zileuton
- Duaklir Pressair Aclidinium Bromide, Formoterol Fumarate
- Singulair Montelukast Sodium
More on asthma: recruiting trials · published research
Related in respiratory: Pulmonary arterial hypertension · COPD · Cystic fibrosis · Idiopathic pulmonary fibrosis · Allergies (allergic rhinitis)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.